The Milken Institute Center for Public Health leveraged our network of thought leaders to maximize learnings from the COVID-19 pandemic, focused on examining the private sector’s role and responsibility in supporting public health. This report uncovers and spotlights innovative and collaborative partnerships that emerged in response to the crisis and offers recommendations to promote and protect public health so that they can be leveraged for the future, both in times of crisis and non-emergencies.
In this report, the Center for Public Health calls for a new model of partnerships focused on Partnerships for Public Purpose that emphasizes sustainable, systemic public impact over the collaborators’ sectors. Through a landscape analysis and discussions with 32 thought leaders, we uncovered three opportunity areas for future focus to strengthen, protect, and sustain public health:
-
Human capital
-
Logistics
-
Data infrastructure
Case studies of each area highlighting best practices and insights demonstrate tangible benefits from employing partnerships that emphasize accountability for the public good and provide a path forward for how to actualize this evolved model.
Related Content
-
FasterCures mobilizes for next phase of work to save lives by improving the global medical R&D system, launches health data initiative
WASHINGTON, October 22, 2018 – FasterCures, the Milken Institute center whose mission is to save lives by speeding medical breakthroughs to patients, is announcing new initiatives to engage the private sector, strengthen global partnerships...Read Article -
Metabolic Mind Award Program Update
The Milken Institute in partnership with the Baszucki Brain Research Fund are pleased to announce the individuals selected to receive the 2022 Metabolic Mind Award for their exceptional contributions to the advancement of understanding...Read Article -
The Costs of Chronic Disease in the U.S.
Americans' chronic health problems and diseases not only come at the expense of individuals well-being, they also constitute a massive burden on the U.S. economy. When including the costs of lost economic productivity, the total costs of...Read Report11 11Hugh Waters and Marlon Graf -
The Promise of Multi-Cancer Early Detection Technologies in Encouraging Research and Development
New blood-based technologies, known as multi-cancer early detection (MCED) tests, are entering the market and can identify multiple cancers early and simultaneously. These tests detect signals found in DNA that cancer cells shed into the...Read Report -
The Impact of Insight: Patient Preferences in Novel Screening Technologies for Cancer
Patient preferences and insights are increasingly considered throughout the medical product life cycle in addition to clinical outcomes. We know that incorporating patient preferences in the product life cycle can create meaningful results...Patient preferences and insights are increasingly considered throughout the medical product life cycle in addition to clinical outcomes. We know that incorporating patient preferences in the product...
11Katie O'Connor and Hadly Clark -
What Kills Americans: Growth of Metabolic Contributors
The most common way to understand the impact of a disease is to track its rates of prevalence and mortality because these metrics are derived from easily collected data. However, prevalence and mortality rates fail to capture whether a...View Research -
Milken Institute Launches COVID-19 Vaccine and Treatment Tracker
Publicly available resource monitors the development of therapies to treat and prevent disease WASHINGTON, March 18, 2020 — The Milken Institute is launching a resource to help the public and policymakers track progress in the development...Read Article -
World Leaders to Descend on Singapore for the 10th Milken Institute Asia Summit, Celebrating a Decade of Progress, Action, and Impact
August 1, 2023 (SINGAPORE) - The annual Milken Institute Asia Summit, taking place from September 13 – 15, will convene regional and global leaders to discuss a wide range of issues and challenges shaping the Asia Pacific region including...Read ArticleImageYeen Chong
Associate Director, Milken Institute InternationalYeen Chee Chong is an associate director for Milken Institute International. Based in Singapore, he oversees and manages strategic communications with a wide range of global and regional media publications and partners. Chong works closely with colleagues in both Asia and the United States on planning and implementing global public relations and social media campaigns. -
Lessons of the Millennium Development Goals
Did the United Nations' ambitious Millennium Development Goals improve the health of people in emerging regions of the world? In this paper, a discussion of the precursors of higher living standards and better health, Milken Institute...Read Report -
Models for Financing Antibiotic Development to Address Antimicrobial Resistance
The Financial Innovations Labs® and FasterCures teams have collaborated on a project to identify new models for financing the antimicrobial resistant antibiotic pipeline. These past 18 months have demonstrated how consequential public...Read Report11
-
Catalyzing Action for Pharmacist-Provided Food Is Medicine Care
"Catalyzing Action for Pharmacist-Provided Food Is Medicine Care" provides background, insights, and actionable recommendations for pharmacies and key partners, including health-care payers and policymakers, to scale FIM interventions in...Read Report -
Improving Early Detection of Cognitive Impairment and Dementia
DOWNLOAD REPORT The prevalence of mild cognitive impairment (MCI) and dementia is increasing as advancements in medicine, public health, and living standards extend human lifespans. Approximately 12–18 percent of Americans aged 60 and older...Read Report11 11
Diane Ty, Soo Borson, MD, and Katie Partrick, PhD